Of chloroquine and COVID-19

Recent publications have brought attention to the possible benefit of chloroquine, a broadly used antimalarial drug, in the treatment of patients infected by the novel emerged coronavirus (SARS-CoV-2). The scientific community should consider this information in light of previous experiments with ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Touret, Franck, de Lamballerie, Xavier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2020
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7132364/
https://www.ncbi.nlm.nih.gov/pubmed/32147496
http://dx.doi.org/10.1016/j.antiviral.2020.104762
Descripción
Sumario:Recent publications have brought attention to the possible benefit of chloroquine, a broadly used antimalarial drug, in the treatment of patients infected by the novel emerged coronavirus (SARS-CoV-2). The scientific community should consider this information in light of previous experiments with chloroquine in the field of antiviral research.

Ejemplares similares